Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 506 entries
View as:

A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01830140 Org: User:
Start: 07/31/13 End: 05/31/14 Due: 05/31/15

Safety and Blood Level Study of Unit Dose Budesonide

Phase: N/A Priority: Normal
NCT ID: NCT00627679 Org: User:
Start: 12/31/05 End: 05/31/06 Due: 05/31/07

A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males

Phase: N/A Priority: Normal
NCT ID: NCT02781311 Org: User:
Start: 07/14/16 End: 05/22/18 Due: 05/22/19

Memantine in Patients With Chronic Glaucoma

Phase: N/A Priority: Normal
NCT ID: NCT00168350 Org: User:
Start: 03/31/00 End: 09/30/06 Due: 09/30/07

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

Phase: N/A Priority: Normal
NCT ID: NCT02357420 Org: User:
Start: 01/29/15 End: 06/09/16 Due: 06/09/17

An Adult Spasticity Registry of OnabotulinumtoxinA Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01930786 Org: User:
Start: 10/16/13 End: 10/09/17 Due: 10/09/18

A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%

Phase: N/A Priority: Normal
NCT ID: NCT00151541 Org: User:
Start: 02/28/05 End: 07/31/05 Due: 07/31/06

Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne

Phase: N/A Priority: Normal
NCT ID: NCT01425320 Org: User:
Start: 01/31/13 End: 06/30/13 Due: 06/30/14

A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting

Phase: N/A Priority: Normal
NCT ID: NCT01999348 Org: User:
Start: 11/25/13 End: 12/19/14 Due: 12/19/15

Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study

Phase: N/A Priority: Normal
NCT ID: NCT02731911 Org: User:
Start: 04/29/16 End: 10/22/18 Due: 10/22/19

A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT01918371 Org: User:
Start: 08/02/13 End: 09/04/14 Due: 09/04/15

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial

Phase: N/A Priority: Normal
NCT ID: NCT00863551 Org: User:
Start: 04/30/09 End: 08/31/09 Due: 08/31/10

Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily

Phase: N/A Priority: Normal
NCT ID: NCT01089751 Org: User:
Start: 03/31/10 End: 06/30/12 Due: 06/30/13

Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence

Phase: N/A Priority: Normal
NCT ID: NCT00693420 Org: User:
Start: 04/30/07 End: 12/31/07 Due: 12/31/08

Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)

Phase: N/A Priority: Normal
NCT ID: NCT02863705 Org: User:
Start: 07/05/16 End: 07/25/18 Due: 07/25/19

Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%

Phase: N/A Priority: Normal
NCT ID: NCT00440141 Org: User:
Start: 07/31/06 End: 03/31/07 Due: 03/31/08

Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT00987727 Org: User:
Start: 11/30/09 End: 09/30/10 Due: 09/30/11

Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00652496 Org: User:
Start: 01/31/05 End: 05/31/05 Due: 05/31/06

Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)

Phase: N/A Priority: Normal
NCT ID: NCT01540370 Org: User:
Start: 02/29/12 End: 07/31/12 Due: 07/31/13

Research Study in Patients With Persistent Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT00035906 Org: User:
Start: 10/31/01 End: 08/31/04 Due: 08/31/05

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00439140 Org: User:
Start: 06/30/07 End: 12/31/12 Due: 12/31/13

MDs on Botox Utility (MOBILITY)

Phase: N/A Priority: Normal
NCT ID: NCT00535938 Org: User:
Start: 09/30/07 End: 09/30/13 Due: 09/30/14

Efficacy of Ketorolac 0.4% in Prostaglandin Suppression

Phase: N/A Priority: Normal
NCT ID: NCT00791323 Org: User:
Start: 11/30/08 End: 08/31/09 Due: 08/31/10

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

Phase: N/A Priority: Normal
NCT ID: NCT03420781 Org: User:
Start: 01/24/18 End: 10/30/20 Due: 10/30/21

Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT00243542 Org: User:
Start: 11/30/05 End: 10/31/06 Due: 10/31/07